EXL — Elixinol Wellness Balance Sheet
0.000.00%
Last trade - 00:00- AU$2.90m
- AU$5.22m
- AU$15.51m
Annual balance sheet for Elixinol Wellness, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 12.6 | 2.86 | 0.708 | 1.08 | 1.41 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.51 | 4.03 | 1.72 | 1.62 | 1.19 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 19.6 | 9.31 | 8.18 | 7.18 | 5.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.48 | 1.11 | 1.19 | 1.43 | 1.24 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 25.3 | 13.5 | 11.7 | 18.4 | 16 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.71 | 3.44 | 4.99 | 4.99 | 6.64 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.25 | 4.33 | 5.25 | 8.42 | 8.51 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19.1 | 9.16 | 6.46 | 10 | 7.45 |
| Total Liabilities & Shareholders' Equity | 25.3 | 13.5 | 11.7 | 18.4 | 16 |
| Total Common Shares Outstanding |